CYTO - Rata-rata rega prakiraan Altamira Therapeutics

Altamira Therapeutics (CYTO) focuses on the development of innovative inhalation systems and RNA therapies, maintaining offices in the US and Switzerland. Currently, its nasal platforms are undergoing the pre-sale licensing stage, while the expansion of the development portfolio is driving up research expenses. This chart reflects an asset value of 5.31, with the business operating on the principles of bioethics and sustainable waste disposal.

CYTO - Bagan rega target Altamira Therapeutics ing rentang 04.07.2022 - 04.01.2025

Rincian analitis perusahaan Altamira Therapeutics (CYTO)

CYTO — sistem indikator bursa lan keuangan altamiratherapeutics.com:

Kutipan saham altamiratherapeutics.com|CYTO - Target konsensus|Nilai pasar Auris Medical

Analisis umum perusahaan:CYTO Altamira Therapeutics Ltd

Barang unggulan Altamira Therapeutics Ltd.

Altamira Therapeutics' development of the OligoPhore platform for RNA drug delivery and its pursuit of partnerships with pharmaceutical behemoths define the business's capitalization potential. The dynamics of the consensus estimated value reflect the weighted average view of investment banks on asset valuation, allowing investors to contrast market noise with the issuer's actual ability to generate cash flow and assess solvency risks through the target price trend.

Pesaing Altamira Therapeutics

Target konsensus haleon.com HLN|Kenvue - Target konsensus|Verona Pharma PLC (VRNA) - Rata-rata rega prakiraan|MENS: Target konsensus|Ligand Corp - Rega prakiraan analis|Amneal Pharmaceuticals (AMRX) - Bagan rega target|Rata-rata rega prakiraan perrigo.com (PRGO)|Bagan rega target Alvotech SA|Liquidia Corp - Bagan tingkat prakiraan|Prakiraan konsensus analis GLPG|ANIP (ANI Pharmaceuticals Corp) - Konsensus nilai wajar|Prakiraan konsensus analis MNKD (MannKind Corporation)|Prakiraan konsensus analis amphastar.com AMPH|PCRX - Bagan rega target|Konsensus nilai wajar SPRY (ARS Pharmaceuticals Inc)|Theravance (TBPH) - Bagan rega target|Target konsensus Aquestive Corp|SCPH (scPharmaceuticals, Inc.) - Prakiraan konsensus analis|Prakiraan konsensus analis Tectonic|Target konsensus TNXP (Tonix Pharmaceuticals Holding Corp.)|SXTC (sxtchina.com) - Konsensus nilai wajar|Bagan rega target Eupraxia Pharmaceuticals Inc. EPRX|BioHarvest Sciences Inc (BHST) - Rata-rata rega prakiraan|EXOZ: Target konsensus|Oramed Pharmaceuticals - Rega prakiraan analis|ENTX: Prakiraan konsensus analis|MindWalk Holdings, Inc. - Konsensus nilai wajar|ABVC (ABVC BioPharma Inc) - Prakiraan konsensus analis|Rata-rata rega prakiraan Cumberland Corp CPIX|Bagan rega target Quantum BioPharma Ltd (QNTM)|FGEN (fibrogen.com) - Konsensus nilai wajar|Prakiraan konsensus analis TELO (Telomir Pharmaceuticals, Inc.)|Prakiraan konsensus analis Rani Therapeutics Holdings RANI|SNYR - Bagan rega target|RLYB: Bagan rega target|LEXX (lexariabioscience.com) - Target konsensus|PULM: Rega prakiraan analis|PTHL (Pheton Holdings Limited) - Prakiraan konsensus analis|Prakiraan konsensus analis Aptorum|Bagan rega target Lyra Therapeutics, Inc (LYRA)|Target konsensus impactbiomedinc.com IBO|Prakiraan konsensus analis TNFA (TNF Pharmaceuticals, Inc.)|Target median analis cbdMD Inc. (YCBD)|PRFX - Bagan rega target|Konsensus nilai wajar LIPO (Lipella Pharmaceuticals Inc)|OPTN: Prakiraan konsensus analis|Pieris Pharma (PIRS) - Prakiraan konsensus analis|Target konsensus PROC|PTPI: Konsensus nilai wajar|Target konsensus QLI (Qilian International Holding)|Rega prakiraan analis SLRN|Prakiraan konsensus analis TFFP (TFF Pharma)